exosome diagnostics

The collaboration among the National Cancer Center Japan, JVCKENWOOD, Sysmex, and Daiichi Sankyo aims to detect cancer-specific exosomes from patients' blood.

The funds will support a variety of business activities including diagnostic test development and the advance of new methods for tissue-specific exosome isolation.

The Swiss biopharmaceutical company said it undertook both deals to develop new therapeutic and diagnostic applications based around exosomes.